Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-04-05
DOI
10.3389/fnagi.2016.00068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of liposome and peptide in the synergistic enhancement of transfection with a lipopolyplex vector
- (2015) Mustafa M. Munye et al. Scientific Reports
- Storage stability of optimal liposome–polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery
- (2014) Alexander Ewe et al. Acta Biomaterialia
- Development of anionic bubble lipopolyplexes for efficient and safe gene transfection with ultrasound exposure in mice
- (2014) Tomoaki Kurosaki et al. JOURNAL OF CONTROLLED RELEASE
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia
- (2013) X. Huang et al. CLINICAL CANCER RESEARCH
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Intranasal and Subcutaneous Administration of Dopamine D3 Receptor Agonists Functionally Restores Nigrostriatal Dopamine in MPTP-Treated Mice
- (2013) Chu Lan Lao et al. NEUROTOXICITY RESEARCH
- Parkinson's Disease: Gene Therapies
- (2013) P. G. Coune et al. Cold Spring Harbor Perspectives in Medicine
- Gene Delivery Using Ternary Lipopolyplexes Incorporating Branched Cationic Peptides: The Role of Peptide Sequence and Branching
- (2012) Katharina Welser et al. MOLECULAR PHARMACEUTICS
- Bioreducible Polymers for Gene Silencing and Delivery
- (2011) Sejin Son et al. ACCOUNTS OF CHEMICAL RESEARCH
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- MicroRNAs in Parkinson's disease
- (2011) Maged M. Harraz et al. JOURNAL OF CHEMICAL NEUROANATOMY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Effective Stabilization and Delivery of siRNA: Reversible siRNA−Phospholipid Conjugate in Nanosized Mixed Polymeric Micelles
- (2010) Tiziana Musacchio et al. BIOCONJUGATE CHEMISTRY
- Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding
- (2010) Yu Nie et al. BIOMATERIALS
- Gene Therapy in Parkinsonʼs Disease
- (2010) Li Rebekah Feng et al. CNS DRUGS
- Progress and prospects: nuclear import of nonviral vectors
- (2010) A P Lam et al. GENE THERAPY
- Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia
- (2010) J. M. Solowska et al. HUMAN MOLECULAR GENETICS
- The Genetics of Parkinson Disease
- (2010) Lynn M. Bekris et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Parkinson's Disease and Cancer
- (2009) Marco D'Amelio et al. Annals of the New York Academy of Sciences
- Pulmonary gene delivery of hybrid vector, lipopolyplex containing N-lauroylsarcosine, via the systemic route
- (2009) Tomoaki Kurosaki et al. JOURNAL OF CONTROLLED RELEASE
- Reducible Disulfide-Based Non-Viral Gene Delivery Systems
- (2009) Defang Ouyang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- Protein stability and aggregation in Parkinson's disease
- (2008) Philip A. Robinson BIOCHEMICAL JOURNAL
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Computer-assisted Hydrodynamic Gene Delivery
- (2008) Takeshi Suda et al. MOLECULAR THERAPY
- Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
- (2007) Shyh-Dar Li et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
- (2007) Shyh-Dar Li et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search